Our results offer a new molecular explanation for the aggressive malignant phenotypes of p53-compromised cancers and suggest that targeting mitochondrial fission and its downstream ERK1/2 signaling pathway may diminish the spread of p53-compromised cancer cells. This evidence concerns the gene MAPK3 and cancer.